Alcidion Group Ltd
Alcidion Group Ltd is a software company that provides clinical decision support systems and digital health solutions to healthcare providers.
Business. Alcidion Group Ltd (ALC.AX) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As specific segment and geographic breakdowns are not provided, the company is described at the industry level. Alcidion Group Ltd is listed under the ticker ALC.AX.
Analyst recommendations
4 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Alcidion Group Ltd (ALC.AX) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription-based model, aligning with industry standards for SaaS businesses. As specific segment and geographic breakdowns are not provided, the company is described at the industry level. Alcidion Group Ltd is listed under the ticker ALC.AX.
Alcidion's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents. The company has no dilution risk in the near term, as shares outstanding for both basic and diluted scenarios are identical at 1.343 billion.
Profitability and returns data are not available for Alcidion, as no valuation snapshot or industry_config preferred metrics are provided. The company's performance relative to cohort medians in the Health Care Technology industry cannot be assessed.
Segment and geographic exposure details are not disclosed in the available data. No revenue concentration or geographic breakdown is provided, limiting visibility into the company's operational diversification.
Growth trajectory is not quantifiable due to the absence of outlook numeric deltas and revenue history. Analysts have issued a mean price target of 0.14 AUD, with a median of 0.14 AUD and a range from 0.12 to 0.16 AUD.
Risk factors include the inability to assess liquidity risk, as no balance-sheet inputs are available. The company has low dilution potential, with no near-term dilution pressure indicated. No adjustments have been applied to valuation metrics due to data limitations.
Recent events and filings are not detailed in the available data. No transcripts or material disclosures are provided to inform recent company developments.
- Alcidion operates in the Health Care Technology industry with a focus on clinical decision support systems.
- The company's liquidity and capital structure remain unassessable due to missing balance-sheet data.
- Analysts have issued a neutral-to-bullish outlook, with a mean price target of 0.14 AUD.
- No material dilution risk is currently present, as shares outstanding are unchanged between basic and diluted scenarios.
- Growth and profitability metrics are not available, limiting the ability to benchmark against industry peers.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue A$40.8M, +10,1% YoY; Operating income +103,7% YoY.
- ▍Revenue A$40.8M, +10,1% YoY
- ▍Operating income +103,7% YoY
- ▍Net income +119,7% YoY
- ▍Free cash flow +240,1% YoY
- ▍Net margin 4.1%
Revenue A$37.1M, −8,3% YoY; Operating income −83,5% YoY.
- ▍Revenue A$37.1M, −8,3% YoY
- ▍Operating income −83,5% YoY
- ▍Net income −132,7% YoY
- ▍Free cash flow −394,3% YoY
- ▍Net margin -22.7%
Revenue A$40.4M, +17,6% YoY; Operating income −21,3% YoY.
- ▍Revenue A$40.4M, +17,6% YoY
- ▍Operating income −21,3% YoY
- ▍Net income +18,0% YoY
- ▍Free cash flow +64,2% YoY
- ▍Net margin -9.0%
Revenue A$34.4M, +32,7% YoY; Operating income −223,2% YoY.
- ▍Revenue A$34.4M, +32,7% YoY
- ▍Operating income −223,2% YoY
- ▍Net income −96,6% YoY
- ▍Free cash flow −17,5% YoY
- ▍Net margin -12.8%
Revenue A$25.9M; Operating income -A$1.2M.
- ▍Revenue A$25.9M
- ▍Operating income -A$1.2M
- ▍Net margin -8.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,00 |
| Revenue | —no estimate | —no estimate | 51,0M AUD |
| Operating income | —no estimate | —no estimate | 1,4M AUD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Alcidion Group Ltd Market data — financials · 2026-05-27
- Alcidion Group Ltd Market data — analyst estimates · 2026-05-27